Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SFIX -18.8%, DRI -5.0%, KGC -3.1%, SNX -2.7%, FUL -2.4%
Other news:
- ACAD -12.1% (Remlifanserin's 60 mg dose missed statistical significance on the Phase 2 RADIANT primary endpoint in Alzheimer's disease psychosis.)
- VKTX -12.0% (Priced upsized offerings of 7.86 million shares at $35 each and $225 million of 2% convertible notes.)
- MGM -9.2% (Confirms People Incorporated withdrew its acquisition proposal, with the board backing MGM's standalone plan.)
- HAFN -5.5% (Priced a 35.49 million-share placement at NOK 80, raising about $300 million to bolster its balance sheet.)
- TMS -4.7% (Closed a $225 million perpetual preferred equity financing carrying a 16% cash dividend to fund acquisitions.)
- MNOV -4.6% (Completed the Phase 2b/3 COMBAT-ALS trial's double-blind portion, with MN-166 topline data expected by year-end 2026.)
- DK -3.1% (Plans $400 million convertible senior notes offering, with proceeds partly funding capped calls and term-loan repayment.)
- SQNS -3.0% (Completes Bitcoin treasury exit, emerging with a solid financial foundation.)
- TRU -2.7% (CFO Todd Cello will step down December 31, while TransUnion reaffirmed third-quarter and full-year guidance.)
- VRT -1.8% (Agreed to acquire King Environmental Services in 4Q26; terms were undisclosed, with immaterial expected financial impact.)
- AFYA -1.8% (Agreed to merge into Yduqs; shareholders would own 69% and Nasdaq shares would delist at closing.)
- RDW -1.5% (Named one of 15 vendors on Space Systems Command's $980 million NITE-STAR contract vehicle, with no guaranteed revenue.)
- ELMT -1.4% (Will acquire a 4.99% stake in Masan High-Tech Materials for $124.75 million under a strategic agreement.)
- VOYG -1.1% (Priced a $350 million private offering of 0% convertible senior notes due 2032, with a $52.5 million option.)